Related Experiment Video
Updated: Aug 5, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Absorption kinetics of vitamins and minerals from a novel nutritional product in physically active adults: a
Philip A Sapp1,2, Jeremy R Townsend1,3, Trevor O Kirby1
1Research, Nutrition, and Innovation, AG1, Carson City, NV, United States.
Background/Objectives:
Nutrient interactions in multi-ingredient supplements may influence micronutrient absorption and bioavailability, yet pharmacokinetic data exploring these interactions remains generally limited. This clinical trial assessed the acute absorption phase of key micronutrients in AG1, a comprehensive nutritional supplement containing vitamins, minerals, probiotics, and phytochemicals.
Methods:
In a randomized, double-blind, placebo-controlled crossover trial 16 healthy adults (8 males and 8 females) consumed a single serving (13 g) of AG1 or a taste- and appearance-matched placebo mixed in water, following a 10-h overnight fast. Each condition was separated by a 1-week washout period. Blood samples were collected 0 (baseline), 30, 60, 90, 120, 180, 240, 360, and 480 min post-ingestion. Plasma concentrations of folate, calcium, zinc, vitamin C, biotin, nicotinamide, pyridoxine, riboflavin, thiamine, and hesperidin were measured. The absorption phase was generally characterized using area under the curve (AUC0-480 min), Cmax, and Tmax. Safety and tolerability were assessed throughout the study. Statistical analysis included repeated-measures ANOVA and paired t-tests.
Results:
AG1 significantly increased AUC0-480 min values (p < 0.05) for all measured nutrients except pyridoxine which revealed a weak trend (p = 0.1205). Both AG1 and placebo were well tolerated, with no serious adverse events reported.
Conclusion:
Acute consumption of AG1 resulted in measurable increases in circulating levels of most of the tested micronutrients, indicating effective absorption. These findings suggest that AG1 may influence nutrient status in healthy adults.
Clinical Trial Registration:
Clinicaltrials.gov, identifier NCT06316700.
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability Study Design: Absolute Versus Relative Bioavailability
Bioavailability Study Design: Single Versus Multiple Dose Studies
Modified-Release Drug Delivery Systems: Bioavailability
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Measurement of Bioavailability: Pharmacodynamic Methods